Common Contracts
2 similar Series a Convertible Preferred Stock Purchase Agreement contracts by Poniard Pharmaceuticals, Inc.
EX-10.50 19 dex1050.htm SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries a Convertible Preferred Stock Purchase Agreement • May 5th, 2020 • New York
This Series A Convertible Preferred Stock Purchase Agreement dated as of October 19, 2005 (the “Agreement”) by and among Allozyne, Inc., a Delaware corporation (the “Company”), the Institute for Systems Biology, a Washington non-profit corporation (“ISB”), ISB Accelerator Corporation, a Delaware corporation (“Accelerator”), Deepshikha Datta, an individual (“Datta”), William A. Goddard, an individual (“Goddard”), and David Tirrell, an individual (“Tirrell”; Datta, Goddard, and Tirrell are each referred to as a “Founder” and collectively as the “Founders”), and the several purchasers named in the attached Schedule I (individually a “Purchaser” and collectively the “Purchasers”; the Purchasers, ISB and Accelerator are each individually an “Investor” and collectively the “Investors”):
SERIES A CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENTSeries a Convertible Preferred Stock Purchase Agreement • September 6th, 2011 • Poniard Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Series A Convertible Preferred Stock Purchase Agreement dated as of October 19, 2005 (the “Agreement”) by and among Allozyne, Inc., a Delaware corporation (the “Company”), the Institute for Systems Biology, a Washington non-profit corporation (“ISB”), ISB Accelerator Corporation, a Delaware corporation (“Accelerator”), Deepshikha Datta, an individual (“Datta”), William A. Goddard, an individual (“Goddard”), and David Tirrell, an individual (“Tirrell”; Datta, Goddard, and Tirrell are each referred to as a “Founder” and collectively as the “Founders”), and the several purchasers named in the attached Schedule I (individually a “Purchaser” and collectively the “Purchasers”; the Purchasers, ISB and Accelerator are each individually an “Investor” and collectively the “Investors”):
